_256_384.png){kind=logo}
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
Immunology remained AbbVie’s largest and fastest-growing segment, delivering $30.41 billion in global net revenues,
A final decision on the updated application is expected in the first half of 2026, while intravenous (IV) Saphnelo remains commercially available
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Subscribe To Our Newsletter & Stay Updated
